Category

CEA/CUA

Home > Project Types > CEA/CUA

Martró E, Domínguez-Hernández R, Forero V, Gómez J, Not A2, Manzanares-Laya S, Montoro M, Gómez-Barrera M, Buti M, Casabona J, Majó X, Colom J

 

 

Cost-effectiveness of community interventions to promote awareness, testing and treatment of hepatitis B and C in migrant populations in Catalonia.
Scientific Reports (In press)

MÁS INFORMACIÓN

Buti M, Aguilera A, Calleja JL, Molero JM, Ryan P, Antón Basanta JJ; Domínguez-Hernández D, De la Cuadra-Grande A, García F

 

 

Recomendaciones de un grupo multidisciplinar de expertos sobre el diagnóstico de pacientes con el virus de la hepatitis delta (VHD) en España
Gastroenterol Hepatol. 2026:502768. English, Spanish. doi: 10.1016/j.gastrohep.2026.502768

de la Cuadra-Grande A, Oltra-Díaz M, Lerma de Antonio M, Casado MÁ, Oyagüez I

 

 

Should the Spanish National Health System Invest in Psychotherapy for Depression? A Microsimulation Cost-Utility Study to Estimate the Economically Justifiable Price of Cognitive Behavioral Therapy Versus Anti-depressant Medication
Appl Health Econ Health Policy. 2025 Dec 23. doi: 10.1007/s40258-025-01022-2

de Pedro S, Presa M, Gamez J, Gómez Fernández FJ, Querol L

 

 

Cost analysis of immunoglobulin maintenance treatment of patients with chronic inflammatory demyelinating polyneuropathy in Spain
Pharmacoecon Open. 2026. doi: 10.1007/s41669-025-00633-8

Robles-Plaza M, Gómez-Peralta F, Bellido V, Ampudia-Blasco FJ, Carretero-Gómez J, Cebrián-Cuenca AM, de la Cuadra-Grande A, Mezquita-Raya P

 

 

Cost-Utility Analysis of FreeStyle Libre Systems in People with Type 2 Diabetes Mellitus on Treatment with Basal Insulin and Poor Glycemic Control in Spain
Diabetes Ther. 2025. doi: 10.1007/s13300-025-01816-6

Rodríguez-Lago I, Muñoz Núñez F, Lucendo AJ, De Lossada Juste A, Cabez A, de la Cuadra-Grande A, Oyagüez I, Monte-Boquet E

 

 

Cost-Effectiveness Analysis of Etrasimod compared with Biologic Therapies for the Treatment of Patients with Moderately-to-Severely Active Ulcerative Colitis in Spain
Pharmacoecon Open. 2025. doi: 10.1007/s41669-025-00619-6

Martró E, Domínguez-Hernández R, Forero V, Gómez J, Not A, Manzanares-Laya S, Montoro M, Gómez-Barrera M, Buti M, Casabona J, Majó X, Colom J

 

Cost-effectiveness of community interventions to promote awareness, testing and treatment of of hepatitis B and C in the migrant population in Catalonia
Jornada Científica CIBERESP. Zaragoza. 28-29 oct 2025
POSTER

Rodríguez-Lago I, Muñoz Núñez F, Lucendo AJ, De Lossada Juste A, Cabez A, de la Cuadra-Grande A, Oyagüez I, Monte-Boquet E

 

 

Cost-effectiveness analysis of etrasimod compared with biologic therapies for patients with moderate-to-severe active ulcerative colitis experienced to previous advanced therapies in Spain
United European Gastroenterology (UEG) Week. Berlin. 4-7 oct 2025

Martró E, Domínguez-Hernández R, Forero V, Gómez J, Not A, Manzanares-Laya S, Montoro M, Gómez-Barrera M, Buti M, Casabona J, Majó X, Colom J

 

Las intervenciones comunitarias para promover la sensibilización, el diagnóstico y el tratamiento de la hepatitis B y C en la población migrante en Cataluña son coste-efectivas
X Congreso Nacional GEHEP. A Coruña. 25-27 sep 2025
POSTER
1 2 3 29